Designated ‘Breakthrough Therapies’ draw support from Calyx
The company’s medical imaging technology and other eClinical solutions reportedly played a part in half of the treatments to receive the FDA designation.
The company’s medical imaging technology and other eClinical solutions reportedly played a part in half of the treatments to receive the FDA designation.
The company has released two products designed to help clinical researchers accelerate development of treatments and vaccines for the COVID-19 virus.
As the COVID-19 vaccines continue the early stages of circulation in the US, the agency keeps an eye on industry actions and offers advice to key players.